MARKET WIRE NEWS

Can This AI Stock Bounce Back in 2026?

Source: Motley Fool

2026-03-08 12:15:00 ET

Artificial intelligence (AI) is all the rage on Wall Street these days, but not every AI stock is equally successful. Some of the bigger names in the field, like Nvidia , have seen their shares soar in recent years, while other, smaller ones, like Recursion Pharmaceuticals (NASDAQ: RXRX) , continue to struggle.

Recursion, a healthcare-focused AI company, could have some catalysts in the next 12 to 18 months, however. Can the stock bounce back this year?

Image source: Getty Images.

Continue reading

Recursion Pharmaceuticals Inc.

NASDAQ: RXRX

RXRX Trading

4.52% G/L:

$3.405 Last:

9,334,431 Volume:

$3.35 Open:

mwn-app Ad 300

RXRX Latest News

March 08, 2026 12:15:00 pm
Can This AI Stock Bounce Back in 2026?

RXRX Stock Data

$2,001,374,702
484,488,629
1.68%
137
N/A
Biotechnology & Life Sciences
Healthcare
US
Salt Lake City

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App